Pay in 4 interest-free payments of $7.05 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Research Applications & Usage Information IGF-1 LR3 (1 mg) is commonly incorporated into laboratory and preclinical research involving: IGF-1 receptor activation and binding affinity studies Myoblast and muscle cell culture experiments Cellular proliferation and differentiation assays Protein synthesis and anabolic signaling research Intracellular signaling pathway analysis (e.g., PI3K/Akt, MAPK/ERK) Comparative evaluation of native IGF-1 versus long-acting analogs Metabolic regulation and glucose-uptake research models Tissue growth and regenerative pathway investigations All applications are investigational and limited to in vitro or preclinical research settings
Important Note on Regulatory Context: The peptide supplement industry has been under increased regulatory scrutiny in recent years
Both are regenerative peptides but operate via distinct mechanisms: BPC-157 (15 residues) drives angiogenesis and GI cytoprotection
The V122I cardiomyopathy variant of transthyretin increases the velocity of rate-limiting tetramer dissociation, resulting in accelerated amyloidosis
It is not approved for use in humans or animals
Other therapies and beyond antioxidants that can provide significant help to the body's detoxificaton process include ozone therapy, dry sauna treatments, exercise, hydrogen therapy, colon irrigation and liver cleansing
US$ 29.13
US$ 20.19
US$ 28.64
US$ 29.24
US$ 25.71
